UAB "Novo Nordisk Pharma"
Okredo company details
Legal status
ActiveCompany ID
300114028VAT code
LT100001731013Incorporation date
12/05/2005Company's manager/representative
MARIJUS VALATKA, Director GeneralShare capital
193,500.00 EURActivity
Wholesale of pharmaceuticalContacts
Website
https://www.novonordisk.lt/Number of employees
29* during past year
Average wage
7,877.20 €* during past year
Debts
0.53 €* during past year
Turnover
21,820,183 €Credit report
25
Data sourcesBusiness linkages
20
LinkagesMonitoring
43
Changes during the yearSimilar companies
415
Similar companiesCompany's value
Register and
explore Okredo dataUAB "Novo Nordisk Pharma" financial ratios
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
2021 |
---|
14,255,889 |
716,017 |
377,747 |
312,935 |
15,717 |
0.04 |
4.35 |
2022 |
---|
16,385,375 |
765,314 |
637,785 |
528,683 |
24,693 |
0.07 |
1.78 |
2023 |
---|
21,820,183 |
935,284 |
912,567 |
752,671 |
32,262 |
0.09 |
2.38 |
Register and
explore Okredo data2023 |
---|
21,820,183 |
935,284 |
912,567 |
752,671 |
32,262 |
0.09 |
2.38 |
Register and
explore Okredo data2023
Turnover (€)
21,820,183 €33 % *
Sales per employee (€)
935,284 €22 % *
Profit before tax (€)
912,567 €43 % *
Net Profit (€)
752,671 €42 % *
Profit per employee (€)
32,262 €31 % *
Working capital requirement
0.09 28.57 % *
Debt-to-equity ratio
2.38 33.71 % *
Credit history
No. of unpaid debts
Register and
explore Okredo dataAmount of unpaid debts
Register and
explore Okredo dataCredit report
Premium users: 1.00 credit
Creditor/Data source | Debt amount | Debt date | Debt type |
---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date / Payment date | Debt type |
---|---|---|---|
- | - | - | - |
Courts
Defendant
(0)
Plaintiff
(0)
3rd party
(0)
Case No./date | Process parties | Case/Court ruling | Court | No. of court hearings | More |
---|---|---|---|---|---|
- | - | - | - | - | - |
Case No./date | Process parties | Case/Court ruling | Court | No. of court hearings | More |
---|---|---|---|---|---|
- | - | - | - | - | - |
Case No./date | Process parties | Case/Court ruling | Court | No. of court hearings | More |
---|---|---|---|---|---|
- | - | - | - | - | - |
ESG data
Energy performance of the company's head office building
Energy efficiency
Vehicles
Company's eco score according CO² of vehicle fleet
Maximum environmental friendliness
Lowest environmental friendliness
Vehicles
CLASS
AMOUNT
Total
0
Eco score | Brand, model | Category | Engine capacity | Fuel |
---|---|---|---|---|
Įmonės vardu transporto priemonės neregistruotos | - | - | - |
Trademarks
Company registered trademarks
No trademarks found
Public data
Govermental support
Institution | Support measure |
---|---|
![]() | Subsidies to preserve work places |
![]() | Subsidies for downtime in 2020 |
![]() | Non-refundable subsidy for micro-enterprises 2020 |
![]() | Fund of ILTE business stimulation means (2020) |
![]() | ILTE business promotion measures (subsidies, compensations) in 2020 |
Register and
explore Okredo dataPublic negative information
Institution | Support measure |
---|---|
![]() | Redundancy of employees group (number of employees notified, date of announcement) |
![]() | Unreliable food processing company |
![]() | Tax inspectorate information on payments in cash |
![]() | Public procurement office information on unreliable suppliers |
![]() | Public procurement office information on those that supplied false data |
Register and
explore Okredo dataPublic data
Institution | Support measure |
---|---|
![]() | Data from the B2Lithuania database of exporters |
![]() | The biggest taxpayers in 2021 |
![]() | Top taxpayers in 2021 excluding excise duties and VAT. |
![]() | Top personal income tax payers in 2021 |
![]() | Top taxpayers for corporate income tax in 2021 |
Register and
explore Okredo dataLicenses
The company has no records of any licenses', permits, certificates, or other licensing documents issued.
Public procurement
No. of won tenders
0* during past yearTotal value of contracts
0 €Number of announced tenders
0* during past yearTotal value of contracts
0 €Date | Procurer/contractor | Amount | Project |
---|---|---|---|
- | - | - | - |
Date | Procurer/contractor | Amount | Project |
---|---|---|---|
- | - | - | - |
Archive of articles
Data source | Article | Date |
---|---|---|
BNS News
Register and
explore Okredo dataSimilar companies
Category:
Wholesale of pharmaceuticalComp. code:
300088003Reg. date:
11/02/2005Turnover:
50-100 M €No. of employees:
43Category:
Wholesale of pharmaceuticalComp. code:
302615244Reg. date:
12/04/2011Turnover:
20-50 M €No. of employees:
22Category:
Wholesale of pharmaceuticalComp. code:
300015222Reg. date:
02/04/2004Turnover:
50-100 M €No. of employees:
35Category:
Wholesale of pharmaceuticalComp. code:
302992398Reg. date:
06/02/2013Turnover:
10-20 M €No. of employees:
22Category:
Wholesale of pharmaceuticalComp. code:
110849177Reg. date:
21/08/2000Turnover:
10-20 M €No. of employees:
19Description
About UAB "Novo Nordisk Pharma"
UAB "Novo Nordisk Pharma" was established in 12/05/2005, its legal status according to data of Registry of Legal Entities is Active.Main activity of the company according NACE2 classification – Wholesale of pharmaceutical, 46.46.20. Company is owned by 1 shareholder. Company's representation right – The rule of quantitative representation.
In 2023 UAB "Novo Nordisk Pharma" turnover was 21,820,183 EUR, gross profit 752,671 EUR. According to SODRA company has 29 employees. UAB "Novo Nordisk Pharma" is registered at – Vilnius, J. Jasinskio g. 16B, LT-03163.
All data about UAB "Novo Nordisk Pharma" is up to date and consistent with the primary data source.